National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
OJEU
Type
Framework (Supply)
Duration
1 year (est.)
Value
£163M
Sector
HEALTH
Published
03 May 2021
Delivery
01 Apr 2021 to 31 Mar 2022 (est.)
Deadline
n/a

Concepts

Location

Runcorn

Geochart for 2 buyers and 93 suppliers

2 buyers

4 suppliers

Description

NHS National framework agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies – North of England. Period of framework agreement: 1 April 2021 to 31 March 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Lot Division

1 Atezolizumab - Lot 1

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
2 Bevacizumab (Avastin) - Lot 2

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
3 Bevacizumab (Zirabev) - Lot 3

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
4 Bevacizumab (Aybintio) - Lot 4

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
5 Bleomycin - Lot 5

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
6 Bortezomib - Lot 6

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
7 Carboplatin - Lot 7

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
8 Cetuximab - Lot 8

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
9 Cisplatin - Lot 9

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
10 Cyclophosphamide Syringes - Lot 10

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
11 Cyclophosphamide Bags - Lot 11

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
12 Cytarabine - Lot 12

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
13 Docetaxel - Lot 13

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
14 Doxorubicin - Lot 14

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
15 Epirubicin - Lot 15

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
16 Fludarabine Syringes - Lot 16

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
17 Fludarabine Bags - Lot 17

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
18 Fluorouracil Syringes - Lot 18

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
19 Fluorouracil Bags - Lot 19

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
20 Fluorouracil in Elastomeric Devices (Folfusor SV0.5) - Lot 20

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
21 Fluorouracil in Elastomeric Devices (Folfusor SV2.5) - Lot 21

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
22 Fluorouracil in Elastomeric Devices (Folfusor LV1.5) - Lot 22

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
23 Fluorouracil in Elastomeric Devices (Folfusor LV5) - Lot 23

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
24 Fluorouracil in Elastomeric Devices (Autofuser 2.5ml/hr) - Lot 24

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
25 Fluorouracil in Elastomeric Devices (Autofuser 2 ml/hr) — Lot 25

The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 36 months.
26 Fluorouracil in Elastomeric Devices (Surefuser) - Lot 26

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
27 Ganciclovir - Lot 27

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
28 Gemcitabine - Lot 28

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
30 Irinotecan - Lot 30

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
31 Methotrexate - Lot 31

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
32 Nivolumab - Lot 32

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
33 Obinutuzumab - Lot 33

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
34 Oxaliplatin - Lot 34

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
35 Paclitaxel - Lot 35

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
36 Panitumumab - Lot 36

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
37 Pembrolizumab - Lot 37

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
38 Pemetrexed - Lot 38

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
39 Pertuzumab - Lot 39

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
40 Rituximab (Mabthera) - Lot 40

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
41 Rituximab (Rixathon) - Lot 41

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
42 Rituximab (Truxima) - Lot 42

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
43 Trastuzumab (Herceptin) - Lot 43

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
44 Trastuzumab (Herzuma) - Lot 44

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
45 Trastuzumab (Kanjinti) - Lot 45

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
46 Trastuzumab (Ontruzant) - Lot 46

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
47 Trastuzumab (Trasimera) - Lot 47

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
48 Vinblastine - Lot 48

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
49 Vincristine - Lot 49

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
50 Vinorelbine - Lot 50

NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.

Award Detail

1 Qualasept (Corsham)
  • Num offers: 1
  • Value: £1
2 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
3 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
4 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
5 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
6 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
7 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
8 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
9 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
10 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
11 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
12 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
13 Quantum Aseptic Services (Burnopfield)
  • Num offers: 3
  • Value: £1
14 Quantum Aseptic Services (Burnopfield)
  • Num offers: 3
  • Value: £1
15 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
16 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
17 Ith Pharma (London)
  • Num offers: 1
  • Value: £1
  • Contractor is an SME.
18 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
19 Qualasept (Corsham)
  • Num offers: 2
  • Value: £1
20 Qualasept (Corsham)
  • Num offers: 2
  • Value: £1
21 Ith Pharma (London)
  • Num offers: 1
  • Value: £1
  • Contractor is an SME.
22 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
23 Ith Pharma (London)
  • Num offers: 1
  • Value: £1
  • Contractor is an SME.
24 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
25 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
26 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
27 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
28 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
29 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
30 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
31 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
32 Ith Pharma (London)
  • Num offers: 1
  • Value: £1
  • Contractor is an SME.
33 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
34 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
35 Ith Pharma (London)
  • Num offers: 1
  • Value: £1
  • Contractor is an SME.
36 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
37 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
38 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
39 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
40 Qualasept (Corsham)
  • Num offers: 1
  • Value: £1
41 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
42 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
43 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
44 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
45 Baxter Healthcare (Newbury)
  • Num offers: 2
  • Value: £1
46 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
47 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
48 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
49 Qualasept (Corsham)
  • Num offers: 1
  • Value: £1
50 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
51 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
52 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
53 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
54 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
55 Ith Pharma (London)
  • Num offers: 3
  • Value: £1
  • Contractor is an SME.
56 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
57 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
58 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
59 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
60 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
61 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
62 Qualasept (Corsham)
  • Num offers: 2
  • Value: £1
63 Qualasept (Corsham)
  • Num offers: 3
  • Value: £1
64 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
65 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
66 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
67 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
68 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
69 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
70 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
71 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
72 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
73 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
74 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
75 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
76 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
77 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
78 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
79 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
80 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
81 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
82 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
83 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
84 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
85 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
86 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
87 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
88 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1
89 Baxter Healthcare (Newbury)
  • Num offers: 4
  • Value: £1
90 Qualasept (Corsham)
  • Num offers: 4
  • Value: £1
91 Ith Pharma (London)
  • Num offers: 4
  • Value: £1
  • Contractor is an SME.
92 Quantum Aseptic Services (Burnopfield)
  • Num offers: 4
  • Value: £1
93 Baxter Healthcare (Newbury)
  • Num offers: 3
  • Value: £1

Award Criteria

PRICE _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Reference

Domains